Pfizer Not Good Against S-African Variant
By Micah Halpern
Saturday April 10, 2021
According to a study done in Israel, the South African COVID variant can “breakthrough” the Pfizer/BioNTech vaccine.
That is not good news. Actually, it is very bad news.
The study was composed of 400 unvaccinated people and 400 double vaccinated people. The result of the study is that people who were not vaccinated were 8 times safer against the South African variant than those who had been vaccinated.
The good news is that there is very little incidence of South African COVID in Israel.
In South Africa however, the variant is predominant.
This study has not yet been peer reviewed. But, the essential lesson to be learned is: do not use the Pfizer vaccine in South Africa.
Read my latest book THUGS. It's easy. Just click.
To reprint my essays contact sales (at) www.featurewell.com